Damage to heart found in more than half of COVID-19 patients...

Washington [US], February 18 (ANI): Around 50 per cent of patients who have been hospitalised with severe COVID-19...

Israeli study shows safety of CD24-Exosomes in COVID-19 patients

New Delhi [India], February 17 (ANI): A preliminary result of an Israeli study to evaluate the safety of EXO-CD24...

Study takes early step towards leukemia drug therapy

Washington (US), February 17 (ANI): During recent research, an important early step in developing a new class of...

Kavitha Kalvakuntla launches another free meal centre in...

Nizamabad (Telangana) [India], February 16 (ANI): With a hope to serve thousands on an hourly basis, Telangana...

Researchers develop new test to help fight deadly melanoma

Washington [US], February 16 (ANI): Researchers have developed a prototype test that can help identify if patients...

Researchers develop new system for identifying drugs to...

Washington [US], February 16 (ANI): A study led by researchers of the Massachusetts Institute of Technology has...

Dr Batra's launches Derma Heal

Mumbai (Maharashtra) [India], February 15 (ANI/PRNewswire): In an effort to provide preventive and effective...

59 Hepatitis treatment centres established in three years...

Chandigarh (Punjab) [India], February 15 (ANI): In view of extending the medical benefits to high-risk groups,...

Digital approaches to address India's healthcare challenges: Fitch

Singapore, February 15 (ANI): Digital solutions will help in creating a comprehensive and integrated healthcare...

Cabozantinib most effective treatment for metastatic...

Washington [US], February 15 (ANI): Recent research in a SWOG Cancer Research Network trial that put three targeted...

Higher risk of heart disease for Type 2 diabetes' patients...

Washington [US], February 14 (ANI): Patients, who suffer from type 2 diabetes and experience extreme swings in their...

Study reveals cabozantinib most effective treatment for...

Washington [US], February 14 (ANI): In a SWOG Cancer Research Network trial that put three targeted drugs to the...